MARIA E CASTILLO-SANCHEZ

Dr. MARIA E CASTILLO-SANCHEZ

IRYCIS-Hospital Ramón y Cajal
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Julie EarlJulie Earl
Julie Earl
EMEmma Barreto Melián
Emma Barreto Melián
MCMARIA E CASTILLO-SANCHEZ
MARIA E CASTILLO-SANCHEZ
RFReyes Ferreiro
Reyes Ferreiro
MRMercedes Rodríguez-Garrote
Mercedes Rodríguez-Garrote
ACAlfredo Carrato
Alfredo Carrato
Pancreatic ductal adenocarcinoma (PDAC) presents many challenges in the clinic and there are many areas for improvement in diagnostics and patient management. The five-year survival rate is around 7.2% as the majority of patients present with advanced disease at diagnosis that is treatment resistant. Approximately 10–15% of PDAC cases have a hereditary basis or Familial Pancreatic Cancer (FPC). Here we demonstrate the use of circulating free DNA (cfDNA) in plasma as a prognostic biomarker in PDAC. The levels of cfDNA correlated with disease status, disease stage, and overall survival. Furthermore, we show for the first time via BEAMing that the majority of hereditary or familial PDAC cases (around 84%) are negative for a KRAS somatic mutation. In addition, KRAS mutation negative cases harbor somatic mutations in potentially druggable genes such as KIT, PDGFR, MET, BRAF, and PIK3CA that could be exploited in the clinic. Finally, familial or hereditary cases have a longer overall survival compared to sporadic cases (10.2 vs. 21.7 months, respectively). Currently, all patients are treated the same in the clinic with cytotoxic agents, although here we demonstrate that there are different subtypes of tumors at the genetic level that could pave the way to personalized treatment.


6 June 2015 in Revista Peruana de Ginecología y Obstetricia
Verified
Journal Article
Open access
PDF file
MCMARIA E CASTILLO-SANCHEZ
MARIA E CASTILLO-SANCHEZ
FNFrancisco Navarro
Francisco Navarro
Resumen Se presenta un caso de pólipos pseudosarcomatosos recidivantes de mucosa uterina endometrial y cervical en una mujer postmenopáusica. Se les diferencia de las lesiones tipo sarcoma botrioides o rabdomiosarcoma por la ausencia de estriación transversal y de rabdomioblastos y la falta de "cambium subpitelial" y de infiltración del epitelio de cubierta por células neoplásicas. Pensamos que este tipo de lesiones podría representar lo que las displasias epiteliales en el cuello uterino. Sin embargo, la baja incidencia con que éstas se presentan no permite concluir por el mmento sobre su evolución y pronóstico.

1 July 2021 in Pancreatology
Verified
Journal Article
Closed access
Julie EarlJulie Earl
Julie Earl
EMEmma Barreto Melián
Emma Barreto Melián
MCMARIA E CASTILLO-SANCHEZ
MARIA E CASTILLO-SANCHEZ
RFR. Fuentes
R. Fuentes
MRM. Rodriguez-Garrote
M. Rodriguez-Garrote
ACAlfredo Carrato
Alfredo Carrato